Product Information

SUCRALFATE 1 GM/10 ML SUSP is a generic product labeled by VistaPharm, LLC, priced at $0.1127 per ML under NDC 66689030516. Its NADAC has been published 227 times since Jul 20, 2022.

FDA first approved this application on Mar 15, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

SUCRALFATE 1 GM/10 ML SUSP

Sucralfate
$0.1127per ML

Strength

1 g/10mL

Manufacturer

VistaPharm, LLC

NDC

66689030516

Classification

Generic

Dosage Form

SUSPENSION

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

SUCRALFATE

Approval Type

Generic (ANDA)

FDA Application

ANDA211884

FDA Approved

3/15/2022

TE Code

AB

On Market Since

3/15/2022

Pharmacological Classes

Aluminum Complex
Organometallic Compounds

Price Statistics

The NADAC for SUCRALFATE 1 GM/10 ML SUSP has been published 227 times since Jul 20, 2022, and over the history we have for it it has declined 66.1%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1127 per ML
All-time high$0.3648 (Nov 16, 2022)
All-time low$0.0907 (Jan 21, 2026)
52-week high$0.1167
52-week low$0.0907
Median price$0.2703
Average price$0.2384
Largest weekly change-14.9% (Sep 17, 2025)
Weeks tracked227
Tracking sinceJul 20, 2022

Price History

1W

-3.4%

1M

-3.1%

3M

-0.1%

6M

+1.7%

1Y

+16.4%

3Y

-60.7%

5Y

N/A

All

-66.1%

Generic Alternatives

The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of SUCRALFATE 1 GM/10 ML SUSP?

The current National Average Drug Acquisition Cost (NADAC) for SUCRALFATE 1 GM/10 ML SUSP, manufactured by VistaPharm, LLC, is $0.1127 per ML (NDC 66689030516), effective Nov 18, 2026.

How has the price of SUCRALFATE 1 GM/10 ML SUSP changed over time?

Over the history we have for it, the NADAC for SUCRALFATE 1 GM/10 ML SUSP has declined 66.1%. It has been tracked across 227 weekly CMS publications since Jul 20, 2022.

What are the highest and lowest recorded NADAC prices for SUCRALFATE 1 GM/10 ML SUSP?

Since Jul 20, 2022, the NADAC for SUCRALFATE 1 GM/10 ML SUSP has ranged from a low of $0.0907 (Jan 21, 2026) to a high of $0.3648 (Nov 16, 2022), with a median of $0.2703 per ML.

Are there cheaper alternatives to SUCRALFATE 1 GM/10 ML SUSP?

6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as SUCRALFATE 1 GM/10 ML SUSP in a comparable dosage form, but none are currently priced below it.

Who manufactures SUCRALFATE 1 GM/10 ML SUSP?

SUCRALFATE 1 GM/10 ML SUSP (NDC 66689030516) is labeled by VistaPharm, LLC, and CMS classifies it as a generic product.